A Clinical Study protocol that agrees alterations to the trial and/or statistical measures of the trial after its initiation without undermining its legitimacy and integrity. The purpose is to make clinical trials more flexible, efficientand fast. Due to the level of flexibility involved, these trial designs are also termed as “flexibledesigns”.
Related: Clinical Trials Conferences| Clinical TrialConferences | Pharmacovigilance Conferences | Clinical Trials Congress |ClinicalTrials Meetings | MedicalConferences | PharmacologyConferences | ClinicalResearch Conferences | Clinical research Society | Clinical Research Associations
Recommended: 9th World Congress on Clinical Pharmacyand Pharmacy Practice Amsterdam, Netherlands March 25-26, 2019, 4thInternational Conference onMedical Microbiology 2019 Vienna, Austria May 20-21, 2019, CPD Accredited8th European ClinicalMicrobiology and ImmunologyCongress Edinburgh, Scotland June 12-13, 2019, International Conference on Clinical Trials& Pharmacovigilance,Prague Czech Republic, September 26 -27 2019. World Congress on Biomarkers andClinical Research, Tokyo, Japan, August 5-6, 2019.
Related Associations: ThePharmaceutical Society of Australia (PSA), AustrianPharmaceutical Society (APS), KoreanResearch-based Pharmaceutical Industry Association (KRPIA), KuwaitPharmaceutical Association (KPA), IndianPharmaceutical Association (IPA).
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
